Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Carmel Pharma AB

Closing information (x1000 EUR)

Closing information 2024/09 2023/09 2022/09
Turnover 6,938 Less Arrow 6,228 More Arrow 6,236
Financial expenses 2 Less Arrow 0 Equal arrow 0
Earnings before taxes 8,678 Less Arrow 7,182 Less Arrow 6,240
EBITDA 6,810 Less Arrow 6,098 More Arrow 6,132
Total assets 41,397 Less Arrow 39,345 More Arrow 45,118
Current assets 131 More Arrow 157 More Arrow 1,428
Current liabilities 8,812 Less Arrow 7,306 More Arrow 11,397
Equity capital 32,584 Less Arrow 32,039 More Arrow 33,721
- share capital 785 Less Arrow 771 More Arrow 812
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/09 2023/09 2022/09
Solvency 78.7% More Arrow 81.4% Less Arrow 74.7%
Turnover per employee
Profit as a percentage of turnover 125.1% Less Arrow 115.3% Less Arrow 100.1%
Return on assets (ROA) 21.0% Less Arrow 18.3% Less Arrow 13.8%
Current ratio 1.5% More Arrow 2.1% More Arrow 12.5%
Return on equity (ROE) 26.6% Less Arrow 22.4% Less Arrow 18.5%
Change turnover 605 Less Arrow 304 More Arrow 1,064
Change turnover % 10% Less Arrow 5% More Arrow 21%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/09 2023/09 2022/09
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.